Vitamin D: Practical Guide and Dose Calculator

Vitamin D goes beyond its traditional classification as a vitamin, functioning as a true steroid hormone with pleiotropic actions in the human body. The discovery of vitamin D receptors (VDR) revolutionized our understanding of its physiological role, revealing its presence in virtually all tissues and organs of the body.

Global and National Epidemiology of Deficiency

Vitamin D deficiency is a global nutritional pandemic, affecting approximately 1 billion people. Paradoxically, even in tropical countries such as Brazil, the prevalence of insufficiency reaches 60% of the population, challenging the paradigm that abundant sun exposure prevents deficiency.

Metabolism and Hormonal Regulation

Vitamin D metabolism involves a complex enzymatic cascade. Cutaneous synthesis of vitamin D3 (cholecalciferol) occurs when UVB radiation (290-315 nm) converts 7-dehydrocholesterol into previtamin D3, which thermally isomerizes into vitamin D3. Alternatively, vitamin D2 (ergocalciferol) can be obtained through the diet.

The first hydroxylation occurs in the liver via 25-hydroxylase (CYP2R1), producing 25(OH)D - the main circulating metabolite and a marker of nutritional status. The second hydroxylation, catalyzed by renal 1α-hydroxylase (CYP27B1), generates the active metabolite 1,25(OH)2D (calcitriol). This process is tightly regulated by PTH, FGF23, and serum calcium and phosphorus.

Laboratory Interpretation and Reference Values

Measuring 25(OH)D is the gold standard for assessing vitamin D status. The updated guidelines of the Endocrine Society 2024 establish:

Clinical Evidence by Organ System

Musculoskeletal System

Robust meta-analyses, including the review in Nature Reviews Endocrinology, demonstrate a 15-30% reduction in fracture risk with adequate vitamin D supplementation combined with calcium. Deficiency impairs proximal muscle strength, increasing fall risk by 22% in older adults.

Immune System

VDR in immune cells modulate innate and adaptive responses. Calcitriol induces production of antimicrobial peptides (cathelicidin, β-defensins) and regulates T cell differentiation. Studies show a 12% reduction in acute respiratory infections with supplementation, an effect more pronounced in individuals with baseline levels < 25 nmol/L.

Cardiovascular System

Consistent observational evidence associates vitamin D deficiency with hypertension (RR 1.3), coronary artery disease (RR 1.4), and cardiovascular mortality (RR 1.35). Mechanisms include downregulation of the renin-angiotensin-aldosterone system and modulation of endothelial function.

Central Nervous System

Brain VDR and 1α-hydroxylase suggest a neuroprotective role. Studies associate deficiency with a higher risk of depression (OR 1.31), cognitive decline (RR 1.21), and multiple sclerosis (RR 1.53 for levels < 30 nmol/L).

Evidence-Based Supplementation Protocols

Individualized dose calculation takes multiple factors into account. The algorithm validated by van Groningen et al. establishes:

Recommended Dosing Regimens

Maintenance (25(OH)D > 30 ng/mL):

• Adults: 1000-2000 IU/day
• Older adults > 70 years: 2000 IU/day
• People with obesity: 3000-6000 IU/day

Deficiency Correction:

• Mild deficiency (20-30 ng/mL): 3000-5000 IU/day for 3 months
• Moderate deficiency (10-20 ng/mL): 6000 IU/day or 50,000 IU/week for 8 weeks
• Severe deficiency (< 10 ng/mL): 10,000 IU/day or a megadose protocol under supervision

Monitoring and Safety

Special Populations: Specific Considerations

Pregnancy and Lactation

Growing evidence supports doses of 2000-4000 IU/day during pregnancy. Maternal deficiency is associated with preeclampsia (OR 1.57), gestational diabetes (OR 1.38), and low birth weight. Maternal levels < 30 nmol/L correlate with a higher risk of autism and schizophrenia in offspring.

Pediatrics

The American Academy of Pediatrics recommends:

• 0-12 months: 400 IU/day (all infants)
• 1-18 years: 600-1000 IU/day
• Premature infants: 400-800 IU/day
• People with obesity: up to 2000 IU/day

Chronic Kidney Disease

Complex management due to reduced 1α-hydroxylase. Requires monitoring of PTH, calcium, and phosphorus. Consider active analogs (calcitriol, paricalcitol) in CKD stages 3-5.

Professional Responsibility Notice: This material is scientific and educational in nature. Interpreting tests and prescribing treatment are medical acts that require individualized clinical evaluation. The evidence presented must be contextualized according to the particularities of each case.

📅 Updated: January 2025 | Based on the 2024 Endocrine Society guidelines and current scientific evidence